Foresite Capital Management V, LLC
- SEC CIK
- 0001792206
In the past year, 1 open-market purchase filing worth $1.00M and no sales.
Current role at each company
- LTGO Latigo Biotherapeutics, Inc.10% Owneras of Aug 10, 2026
- ALMS Alumis Inc.10% Owneras of Apr 3, 2026
- EIKN Eikon Therapeutics, Inc.10% Owneras of Feb 6, 2026
- KNTE Kinnate Biopharma Inc.10% Owneras of Apr 5, 2024
- PRDS Pardes Biosciences, Inc.10% Owneras of Aug 31, 2023
Show 2 more companies
- THRX Theseus Pharmaceuticals, Inc.10% Owneras of Jul 19, 2023
- ACRS Aclaris Therapeutics, Inc.10% Owneras of Nov 3, 2021
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- $1.00M
- 1 filing
- Sold
- –
- 0 filings
- Net
- +$1.00M
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Foresite Capital Management V, LLC as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
LTGO Latigo Biotherapeutics, Inc.
10% Owner1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 10, 2026 (view filing)8:21 PM ET | Aug 10 | Same day | Foresite Capital Fund V, L.P. and 5 others10% Owner | PPurchase | +140.0K | $18.00 | +$2.52M | +7.5%2.01M after | Duplicate filing |
EIKN Eikon Therapeutics, Inc.
10% Owner1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 6, 2026 (view filing)7:37 PM ET | Feb 4 | 2 days | Foresite Capital Fund IV, L.P. and 7 others10% Owner | PPurchase | +55.6K | $18.00 | +$1.00M | +4.4%1.32M after |
ALMS Alumis Inc.
10% Owner5 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jan 12, 2026 (view filing)9:58 PM ET | Jan 8 | 4 days | Foresite Capital Fund V, L.P. and 8 others10% Owner | PPurchase | +411.8K | $17.00 | +$7.00M | +16.5%2.91M after | 2 lotsDuplicate filing |
| Nov 25, 2025 (view filing)4:02 PM ET | Nov 21 | 4 days | Foresite Capital Fund V, L.P. and 8 others10% Owner | PPurchase | +72.2K | $7.38 | +$532.9K | +2.8%2.61M after | Duplicate filing |
| Nov 19, 2025 (view filing)8:52 PM ET | Nov 17-19 | 2 days | Foresite Capital Fund V, L.P. and 8 others10% Owner | PPurchase | +507.9K | $6.09 | +$3.09M | +25.0%2.54M after | 4 lotsDuplicate filing |
| May 6, 2025 (view filing)9:47 PM ET | May 2-6 | 4 days | Foresite Capital Fund V, L.P. and 8 others10% Owner | PPurchase | +45.0K | $4.50 | +$202.3K | +1.1%4.25M after | 2 lotsDuplicate filing |
| Jul 3, 2024 (view filing)9:30 PM ET | Jul 1 | 2 days | Foresite Capital Fund V, L.P. and 8 others10% Owner | PPurchase | +2.50M | $16.00 | +$40.0M | +146.8%4.20M after | 2 lotsDuplicate filing |
THRX Theseus Pharmaceuticals, Inc.
10% Owner2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 19, 2023 (view filing)2:54 PM ET | Jul 17 | 2 days | Tananbaum James B. and 4 others10% Owner | PPurchase | +700.0K | $2.97 | +$2.08M | +102.1%1.39M after | 2 lots |
| Jan 3, 2023 (view filing)4:24 PM ET | Dec 29, 2022 | 5 days | Tananbaum James B. and 4 others10% Owner | PPurchase | +500.0K | $5.00 | +$2.50M | +70.5%1.21M after | 2 lots |
KNTE Kinnate Biopharma Inc.
10% Owner1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 10, 2023 (view filing)5:42 PM ET | May 8 | 2 days | Foresite Capital Fund IV, L.P. and 5 others10% Owner | PPurchase | +1.78M | $2.80 | +$4.98M | New position520.7K after | 2 lotsDuplicate filing |
PRDS Pardes Biosciences, Inc.
10% Owner3 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Apr 6, 2023 (view filing)9:08 PM ET | Apr 5 | 1 day | Tananbaum James B. and 2 othersDirector, 10% Owner | PPurchase | +774.0K | $1.50 | +$1.16M | +6.0%13.6M after | |
| Dec 5, 2022 (view filing)4:24 PM ET | Dec 1 | 4 days | Tananbaum James B. and 2 othersDirector, 10% Owner | PPurchase | +637.4K | $0.85 | +$541.8K | +5.2%12.8M after | |
| Dec 23, 2021 (view filing)4:52 PM ET | Dec 22 | 1 day | Tananbaum James B. and 4 othersDirector, 10% Owner | PPurchase | +325.0K | $10.00 | +$3.25M | New position325.0K after |